Evidence map›Paper›PMID 20150970›Full record

ArticleJournal of biomedicine & biotechnology2010

Substance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosis.

Armandina Garza, David J Tweardy, Joel Weinstock, Balaji Viswanathan, Prema Robinson

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedicine & biotechnology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Armandina GarzaSection of Infectious Disease, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
David J Tweardy
Joel Weinstock
Balaji Viswanathan
Prema Robinson
Baylor College of Medicine · USTufts Medical Center · US

Funding

Neuropeptides in the pathogenesis of neurocysticercosisR01NS042604 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI ROBINSON, PREMA · 2003 to 2007
$1.2M
NINDS NIH HHS 1 R01 NS042604-01A2NINDS NIH HHS R01 NS042604
6 · The paper itself

Abstract

Cysticercosis is an infection with larval cysts of the cestode Taenia solium. Through pathways that are incompletely understood, dying parasites initiate a granulomatous reaction that, in the brain, causes seizures. Substance P (SP), a neuropeptide involved in pain-transmission, contributes to inflammation and previously was detected in granulomas associated with dead T. crassiceps cysts. To determine if SP contributes to granuloma formation, we measured granuloma-size and levels of IL-1beta, TNF-alpha, and IL-6 within granulomas in T. crassiceps-infected wild type (WT) mice and mice deficient in SP-precursor (SPP) or the SP-receptor (neurokinin 1, NK1). Granuloma volumes of infected SPP- and NK1-knockout mice were reduced by 31 and 36%, respectively, compared to WT mice (P < .05 for both) and produced up to 5-fold less IL-1beta, TNF-alpha, and IL-6 protein. Thus, SP signaling contributes to granuloma development and proinflammatory cytokine production in T. crassiceps infection and suggests a potential role for this mediator in human cystercercosis.

Indexed as

AnimalsCysticercosisDisease Models, AnimalFemaleGranulomaInterleukin-1betaInterleukin-6MiceMice, KnockoutReceptors, Neurokinin-1Signal TransductionSubstance PTaeniaTaeniasisTumor Necrosis Factor-alphaInterleukin-1betaInterleukin-6Receptors, Neurokinin-1Substance PTumor Necrosis Factor-alpha

Identifiers

PMID20150970
PMCPMC2817809
OpenAlexW2004324742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.